Kneat.Com Insider Trading

TSX: KSI


2

All Trades

1

Significant

1

Notable

0

Clusters

2

Repeat

CompanyInsiderTitleDateSharesPriceValueBalanceIncreaseSignal
Kneat.ComO’Reilly, DaveSenior Officer19-Nov-2529,500$4.03$118,88536,154443%Significant Repeat
Kneat.ComO’Reilly, DaveCFO17-Nov-256,654$4.13$27,4906,654NewNotable Repeat

Stock Chart

Company Info

Kneat.com is a Canadian software company that develops cloud-based validation lifecycle management solutions for regulated industries. The company provides digital platforms that help organizations manage validation processes, compliance documentation, and quality assurance activities. Their primary product, Kneat Gx, is a configurable validation execution management system designed to streamline and digitize validation workflows for pharmaceutical, biotechnology, medical device, and other life sciences companies.

The company operates globally with headquarters in Limerick, Ireland, and offices in Canada and the United States. Kneat serves clients across multiple continents, including major pharmaceutical manufacturers and contract research organizations. Their platform helps customers transition from paper-based validation processes to digital systems, reducing project timelines and improving compliance efficiency.

Kneat went public in 2019 and has been expanding its customer base through both direct sales and partnerships with system integrators. The company focuses on serving highly regulated industries where validation and compliance documentation are critical requirements. Their software solutions are designed to integrate with existing enterprise systems and support Good Manufacturing Practice standards required in pharmaceutical manufacturing and other regulated environments.